DAFNA Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

DAFNA Capital Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,516	Closed	-$523K	–	96
2022 Q1	$523K	Hold	10,516	–	–	0.14%	81
2021 Q4	$794K	Hold	10,516	–	–	0.2%	70
2021 Q3	$831K	Hold	10,516	–	–	0.22%	68
2021 Q2	$1.46M	Sell	10,516 -2,150	-17%	-$410K	0.31%	65
2021 Q1	$2.65M	Buy	12,666 +4,154	+49%	+$833K	0.63%	39
2020 Q4	$1.41M	Hold	8,512	–	–	0.42%	50
2020 Q3	$1.45M	Hold	8,512	–	–	0.47%	46
2020 Q2	$1.41M	Sell	8,512 -6,235	-42%	-$973K	0.41%	47
2020 Q1	$1.71M	Buy	+14,747	New	+$2.07M	0.71%	37

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DAFNA Capital Management's HARP Position: Q2 2022 in Review

DAFNA Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 10,516 shares — an estimated $523K sold.

DAFNA Capital Management first reported a position in HARP in Q1 2020 and held it in 9 quarters. The position peaked at $2.65M in Q1 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

DAFNA Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
DAFNA Capital Management sold 10,516 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $523K.
DAFNA Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
DAFNA Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $2.65M in Q1 2021.
63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on DAFNA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.